Phase III Study of Gemcitabine Plus Paclitaxel Versus Paclitaxel in Patients With Unresectable, Locally Recurrent or Metastatic Breast Cancer
收藏DataCite Commons2025-11-14 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004363/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known if paclitaxel is more effective with or without gemcitabine for advanced breast cancer. PURPOSE: Randomized phase III trial to study the effectiveness of paclitaxel with or without gemcitabine in treating women who have advanced breast cancer.
提供机构：
Vivli
创建时间：
2019-09-09
